Research programme: pikfyve inhibitors - Verge Genomics
Alternative Names: PIKfyve inhibitors - Verge GenomicsLatest Information Update: 28 Jul 2024
At a glance
- Originator Verge Genomics
- Class Antivirals; Small molecules
- Mechanism of Action PIKFYVE protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported COVID 2019 infections
Most Recent Events
- 28 Jul 2024 No recent reports of development identified for preclinical development in COVID-2019-infections in USA (PO)